To view this email as a web page, click here.

 
Multiple Sclerosis Update: 5 Things to Know
What’s new in MS: extended interval natalizumab dosing, a potential disease activity biomarker, the “MS hug,” virtual reality therapy, and more.
Image ©sfam_photo/Shutterstock.com
Read more
 
Stem Cell Therapy in Neurology
Insights about where stem cell treatment of neurological diseases is headed.
Image ©Catalin/adobe.stock.com
Read more
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.